Abstract
Dr. McCall will review the data on the improvement in quality of life after treatment with ECT supporting the relationship of ECT treatment with significant improvements in mental health of older adults with severe recurrent depression. Dr. Petrides will summarize the data from the CORE group which over several decades has provided a roadmap to increasing the efficacy of ECT while minimizing cognitive side effects and preventing relapse. Dr. Hermida will discuss the use of ultrabrief right unilateral ECT (UB RUL), a form of ECT that may be particularly beneficial in the elderly due to the decreased cognitive side effects. She will review a case study of 100 patients treated with UB RUL who were diagnosed with psychotic depression and catatonia. Dr. Kellner will conclude with a discussion of the use of ECT in the United States. He will review the status of the use (actually underuse) of ECT in the United States. Recent data on the number of procedures performed, demographics of ECT patients, health economic impact of ECT, and details of how ECT is administered (technique, setting, practitioner information) will be covered. Given the suicide epidemic and the increased prevalence of treatment resistant depression, ECT remains a vital treatment for severe mood and psychotic disorders. Newer data suggest increased use of ECT could lead to improved public health outcomes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
